Top Core and Group Health Stories
Drug costs are 3X in the U.S. what other countries pay, study finds
By Scott WooldridgeIndustry observers said that drug companies are likely to continue to oppose the government's efforts to reduce prices.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
Industry observers said that drug companies are likely to continue to oppose the government's efforts to reduce prices.